0 CHECKOUT

Landesbank Hessen-Thueringen Girozentrale-Supported CP Programs on CreditWatch Negative Dec 99

  • ID: 1789120
  • December 1999
  • Standard & Poors
1 of 3

Abstract
NEW YORK (Standard & Poor's CreditWire) Dec. 7, 1999-- Standard & Poor's today placed two Landesbank Hessen-Thueringen Girozentrale-supported commercial paper programs on CreditWatch with negative implications. The two programs affected by this rating action are listed below, Standard & Poor's said. -- CreditWire LANDESBANK HESSEN-THUERINGEN GIROZENTRALE-SUPPORTED CP PROGRAMS RATINGS PLACED ON CREDITWATCH NEGATIVE MSMC Realty Corp. $75.0 million CP program A-1+ New York St Dorm Auth $6.089 million CP program A-1+...

Companies mentioned in this report are:
- Landesbank Hessen-Thueringen Girozentrale
- Dorm Auth of the St of New York

Action: On CreditWatch:Negative

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Landesbank Hessen-Thueringen Girozentrale
- Dorm Auth of the St of New York

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.